Gilead Sciences Covid-19 Virus hospital reports Gilead Sciences

Remdesivir promising for COVID-19; malaria drugs, not so much

Remdesivir, an experimental antiviral drug from Gilead Sciences, has shown promise based on early results in people with severe COVID-19, the disease caused by the new coronavirus.

But experts caution that data from randomized studies are still needed to determine if the medication is safe and effective. "While it is reassuring to hear reports of cohorts with good outcomes, it is impossible to interpret the impact that remdesivir is having on a group that has been treated with this drug in the

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News